Latest total liabilities for REVBW: $2.4M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest total liabilities for REVBW is $2.4M as of June 2026. That compares with $1.6M in the prior-year period — up 54.9% year over year. Investors often review this figure alongside Revelation Biosciences- Warrants(10/01/2027)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, REVBW's total liabilities moved from $1.6M to $2.4M — a 54.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Revelation Biosciences- Warrants(10/01/2027)'s operating scale or balance-sheet position.
A total liabilities figure of $2.4M for REVBW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting REVBW's total liabilities ($2.4M), review year-over-year change from $1.6M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.